Delivery Order SPE2DR25D3111-SPE2DR26FF4BA
Award Date 1/27/26
Potential Completion Date 1/28/26
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., received a delivery order award from the Defense Logistics Agency (DLA) on January 28, 2026, for Lantus SoloStar 100 Unit/mL 3mL insulin pens, valued at $2,018.11. The award is a firm fixed-price delivery order with no set-aside designation, indicating competitive procurement. Performance will be executed at the awardee's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 29, 2026....
- AmerisourceBergen Drug Corp has been awarded a competitively competed delivery order by the Defense Logistics Agency (DLA) for Lantus SoloStar 100 Unit/ML insulin pens, valued at $1,294.28. The order, issued on November 12, 2025, with an ultimate completion date of November 13, 2025, represents a firm fixed price transaction with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this delivery requirement from its corporate office location....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on June 17, 2025, for Lantus SoloStar 100 Unit/mL 3mL insulin pens with a ceiling value of $3,414.70. This firm fixed price delivery order, with an ultimate completion date of June 18, 2025, represents a single-unit transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The award...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp (a subsidiary of Cencora, Inc.) on January 12, 2026, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens with a ceiling value of $1,397.57. This is a firm fixed-price, non-set-aside contract with a completion date of January 13, 2026, and represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The prime IDC, valued at up to $999.9 million...
- The Defense Logistics Agency awarded a delivery order valued at $1,357.52 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ml 3ml insulin pens on January 16, 2026, with a completion date of January 20, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger...
- On January 9, 2026, the Defense Logistics Agency awarded a delivery order valued at $1,008.75 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens. The award was made on a firm fixed-price basis with no set-aside designation, indicating full and open competition. Performance will be completed by January 12, 2026, with fulfillment based in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc.,...
- The Defense Logistics Agency awarded a delivery order valued at $1,423.10 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 7, 2026, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens. This competitively awarded, firm fixed-price delivery order is non-set-aside and carries a completion deadline of January 8, 2026. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution...
- The Defense Logistics Agency (DLA) awarded a delivery order to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 23, 2026, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens. This firm fixed-price delivery order, valued at $1,299.72, carries an ultimate completion date of January 26, 2026, and will be performed at Amerisourcebergen's facility in Conshohocken, Pennsylvania. The award was made on a non-set-aside, competitive basis, reflecting the company's...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,075.50 by the Defense Logistics Agency (DLA) for Lantus SoloStar 100 Unit/ml insulin in 3ml formulations. This is a firm fixed price, competitively awarded contract with no set-aside designation, representing a child order under a larger contract vehicle. The award was made on December 30, 2025, with an ultimate completion date of December 31, 2025, and will be performed at AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Lantus SoloStar 100 Unit/ML 3ML insulin pens, with a contract ceiling value of $1,485.00. This is a firm fixed price delivery order under a non-set-aside competitive procurement, with an ultimate completion date of January 6, 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...